Literature DB >> 28677145

Nerve growth factor regulation and production by macrophages in osteoarthritic synovium.

S Takano1, K Uchida1, G Inoue1, M Miyagi1, J Aikawa1, D Iwase1, K Iwabuchi2, T Matsumoto3, M Satoh2, M Mukai1, A Minatani1, M Takaso1.   

Abstract

Nerve growth factor (NGF) functions to modulate osteoarthritis (OA)-associated pain. Although recent studies suggest that tumour necrosis factor (TNF)-α and interleukin (IL)-1β mediate NGF activity in human synovial fibroblasts, the regulation of NGF expression in human synovial macrophages remains unclear. Here, we examined the role of macrophages in the production and regulation of synovial (SYN) NGF in osteoarthritic knee joints by examining the mRNA expression of TNF-α and IL-1β in freshly isolated CD14-positive (macrophage-rich fraction) and CD14-negative cells (fibroblast-rich fraction) in synovial tissue from OA patients by quantitative polymerase chain reaction. We also examined the effects of IL-1β and TNF-α on NGF mRNA expression in cultured CD14-positive (macrophage-rich fraction) and CD14-negative cells (fibroblast-rich fraction). In addition, to examine the contribution of macrophages to NGF, TNF-α and IL-1β expression, we injected clodronate liposomes systemically into STR/Ort mice, an osteoarthritis animal model, to deplete macrophages. TNF-α and IL-1β mRNA levels in CD14-positive cells from the SYN of OA patients was significantly higher than that in CD14-negative cells, while NGF expression did not differ markedly between the two cell fractions. In addition, treatment of human cultured CD14-positive and -negative cells with IL-1β and TNF-α enhanced NGF mRNA and protein levels. Expression of NGF, IL-1β and TNF-α was also reduced significantly in STR/Ort mice upon macrophage depletion. These findings suggest that IL-1β and TNF-α regulate NGF expression and production in synovial macrophages and fibroblasts in osteoarthritic joints.
© 2017 British Society for Immunology.

Entities:  

Keywords:  macrophage; nerve growth factor; osteoarthritis; synovium

Mesh:

Substances:

Year:  2017        PMID: 28677145      PMCID: PMC5629442          DOI: 10.1111/cei.13007

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  [Animal models for bone and joint disease. Mouse models develop spontaneous osteoarthritis].

Authors:  Ken Watanabe; Yasuhiro Oue; Shiro Ikegawa
Journal:  Clin Calcium       Date:  2011-02

2.  Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons.

Authors:  K A Park; J C Fehrenbacher; E L Thompson; D B Duarte; C M Hingtgen; M R Vasko
Journal:  Neuroscience       Date:  2010-09-24       Impact factor: 3.590

Review 3.  Neurotrophins: mediators and modulators of pain.

Authors:  Sophie Pezet; Stephen B McMahon
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

4.  Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain.

Authors:  Panna Sanga; Nathaniel Katz; Elena Polverejan; Steven Wang; Kathleen M Kelly; Juergen Haeussler; John Thipphawong
Journal:  Pain       Date:  2013-06-05       Impact factor: 6.961

Review 5.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.

Authors:  W Zhang; R W Moskowitz; G Nuki; S Abramson; R D Altman; N Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell
Journal:  Osteoarthritis Cartilage       Date:  2008-02       Impact factor: 6.576

6.  Synovial macrophage-derived IL-1β regulates the calcitonin receptor in osteoarthritic mice.

Authors:  S Takano; K Uchida; M Miyagi; G Inoue; J Aikawa; H Fujimaki; A Minatani; M Sato; K Iwabuchi; M Takaso
Journal:  Clin Exp Immunol       Date:  2015-10-28       Impact factor: 4.330

7.  Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response.

Authors:  L Manni; T Lundeberg; S Fiorito; S Bonini; E Vigneti; L Aloe
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

8.  The factors associated with pain severity in patients with knee osteoarthritis vary according to the radiographic disease severity: a cross-sectional study.

Authors:  Y Shimura; H Kurosawa; Y Sugawara; M Tsuchiya; M Sawa; H Kaneko; I Futami; L Liu; R Sadatsuki; S Hada; Y Iwase; K Kaneko; M Ishijima
Journal:  Osteoarthritis Cartilage       Date:  2013-09       Impact factor: 6.576

9.  Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis.

Authors:  Sadaf Ashraf; Paul Ian Mapp; James Burston; Andrew John Bennett; Victoria Chapman; David Andrew Walsh
Journal:  Ann Rheum Dis       Date:  2013-07-13       Impact factor: 19.103

10.  Adrenomedullin Regulates IL-1β Gene Expression in F4/80+ Macrophages during Synovial Inflammation.

Authors:  Shotaro Takano; Kentaro Uchida; Masayuki Miyagi; Gen Inoue; Jun Aikawa; Kazuya Iwabuchi; Masashi Takaso
Journal:  J Immunol Res       Date:  2017-02-19       Impact factor: 4.818

View more
  25 in total

1.  Acupuncture reduces pain in rats with osteoarthritis by inhibiting MCP2/CCR2 signaling pathway.

Authors:  Bocun Li; Li Jing; Li Jia; Tan Qian; Chen Jianyi; Huang Zhongsheng; Zhou Xiaohong; Cai Guowei
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 2.  The innate immune response as a mediator of osteoarthritis pain.

Authors:  R J Miller; A-M Malfait; R E Miller
Journal:  Osteoarthritis Cartilage       Date:  2019-12-17       Impact factor: 6.576

Review 3.  Therapeutic options for targeting inflammatory osteoarthritis pain.

Authors:  Philip G Conaghan; Andrew D Cook; John A Hamilton; Paul P Tak
Journal:  Nat Rev Rheumatol       Date:  2019-06       Impact factor: 20.543

4.  Microglial Depletion with Clodronate Liposomes Increases Proinflammatory Cytokine Levels, Induces Astrocyte Activation, and Damages Blood Vessel Integrity.

Authors:  Xiaoning Han; Qian Li; Xi Lan; Leena El-Mufti; Honglei Ren; Jian Wang
Journal:  Mol Neurobiol       Date:  2019-02-08       Impact factor: 5.590

5.  Vascular endothelial growth factor expression and their action in the synovial membranes of patients with painful knee osteoarthritis.

Authors:  Shotaro Takano; Kentaro Uchida; Gen Inoue; Toshihide Matsumoto; Jun Aikawa; Dai Iwase; Manabu Mukai; Masayuki Miyagi; Masashi Takaso
Journal:  BMC Musculoskelet Disord       Date:  2018-06-26       Impact factor: 2.362

6.  Transforming growth factor-β stimulates nerve growth factor production in osteoarthritic synovium.

Authors:  Shotaro Takano; Kentaro Uchida; Makoto Itakura; Dai Iwase; Jun Aikawa; Gen Inoue; Manabu Mukai; Masayuki Miyagi; Kosuke Murata; Hiroyuki Sekiguchi; Masashi Takaso
Journal:  BMC Musculoskelet Disord       Date:  2019-05-10       Impact factor: 2.362

Review 7.  Nerve Growth Factor and Pathogenesis of Leprosy: Review and Update.

Authors:  Tinara Leila de Souza Aarão; Jorge Rodrigues de Sousa; Aline Semblano Carreira Falcão; Luiz Fábio Magno Falcão; Juarez Antônio Simões Quaresma
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

8.  The effect of lycopene in egg shell membrane guidance channel on sciatic nerve regeneration in rats.

Authors:  Gholam Hossein Farjah; Samad Mohammdzadeh; Masoumeh Zirak Javanmard
Journal:  Iran J Basic Med Sci       Date:  2020-04       Impact factor: 2.699

9.  Locating human splenic capillary sheaths in virtual reality.

Authors:  B S Steiniger; V Wilhelmi; M Berthold; M Guthe; O Lobachev
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

10.  Select Biomarkers on the Day of Anterior Cruciate Ligament Reconstruction Predict Poor Patient-Reported Outcomes at 2-Year Follow-Up: A Pilot Study.

Authors:  Christian Lattermann; Caitlin E-W Conley; Darren L Johnson; Emily K Reinke; Laura J Huston; Janet L Huebner; Ching-Heng Chou; Virginia B Kraus; Kurt P Spindler; Cale A Jacobs
Journal:  Biomed Res Int       Date:  2018-07-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.